Psilocybin

In Hawaii, the Senate Health Committee approved a bill to set up a state working group to study the therapeutic benefits of psilocybin mushrooms, reported Marijuana Moment. The committee unanimously passed the proposal in a 5-0 vote.  The text of the measure says that “because the State...

Reps. Daniel Pae (R) and Logan Phillips (R) from Oklahoma, filed bills meant to promote research into the therapeutic potential of psilocybin. The proposals are designed to give the legislature different options with similar scientific study objectives, but a key difference is that Pae’s...

Bipartisan members of Congress sent a letter on Tuesday requesting that the Drug Enforcement Administration (DEA) allow terminally ill patients to use psilocybin as an investigational treatment without the fear of federal prosecution, reported Marijuana Moment.  The letter to the DEA,...

Psychedelic treatments are on the cusp of being accepted therapies for the masses. Good data will likely help drive best practices. The field of psychedelic discovery currently exists in two distinct domains: clinical studies conducted by scientists under strict lab conditions, many pursuing FDA...

A New York lawmaker introduced a bill this week to legalize psilocybin mushrooms for medical purposes and establish facilities where the psychedelic could be grown and administered to patients. Assemblyman Pat Burke (D) filed the legislation, which would create a system in New York that is...

Legal psychedelic medicine is poised to soon disrupt the multibillion-dollar mental health field. Treatments being trialed today in clinical settings using substances like psilocybin-containing mushrooms will soon offer legal alternatives to the more than 50 percent of patients receiving therapy...

The Drug Enforcement Administration (DEA), has increased its quota for the legal production of psychedelic drugs such as psilocybin (also known as magic mushrooms), MDMA and DMT for 2022.  This move by the DEA comes amid an increase of demand and interest within the scientific community...

As COMPASS Pathways (NASDAQ: CMPS) crunches more data from a recent trial investigating psilocybin therapy for treatment-resistant depression (TRD), findings show that a higher dose of 25mg (compared to 1mg and 10mg) occasioned an increase in positive feelings of interest in life and a decrease in...

Demonstrating the integrity of its supply chain from Jamaica into Canada, biotechnology company HAVN Life Sciences (OTCPK: HAVLF) achieved a milestone with international delivery - not an easy task. Moving controlled substances transnationally is fraught with...

In the quest to design effective and affordable psychedelic treatments for a range of maladies that include PTSD and depression, one key thought on the minds of company executives and clinicians alike seems to be how to motivate healthcare insurance companies to cover the cost of psychedelic...

The state of Pennsylvania is poised to become a leader in psychedelic research after a bill known as the Public Health Benefits of Psilocybin Act was introduced recently in the House of Representatives. The proposed legislation looks to create a framework for clinical studies of psilocybin,...

Co-written by Andrew Ward and Natan Ponieman The race is continually heating up in the psychedelics space. An array of companies, educational institutions and investors have already obtained patents on formulations, processes, compounds and other aspects of psychedelics treatment. The race has...

Citron Research editor and notorious short seller Andrew Left discussed one of his latest stock ideas during an appearance on Benzinga’s PreMarket Prep show this week. COMPASS Pathways PLC (NASDAQ: CMPS) shares may have ended Tuesday's session down 3.76%, but Left has a bullish thesis for...

Psychedelic and nutraceutical brand Cybin Corp. and drug delivery company IntelGenx have partnered to develop oral dissolving film for psilocybin consumption. Why Does It Matter? Cybin Chief Executive Officer Paul Glavine says "orally-dissolving psilocybin film" bypasses the...

In an unprecedented move, Denver will become the first city in the U.S. to decriminalize psychedelic psilocybin mushrooms.  What Happened For the past month, people in Denver have been voting on the Initiative 301, which deprioritizes the imposition of criminal penalties on the personal...